AU Patent

AU2025205489A1 — Liquid tasimelteon formulations and methods of use thereof

Assigned to Vanda Pharmaceuticals Inc · Expires 2025-08-14 · 1y expired

What this patent protects

#$%^&*AU2025205489A120250814.pdf##### Abstract Liquid suspensions oftasimelteon and methods for their use. Abstract Liquid suspensions oftasimelteon and methods for their use.

USPTO Abstract

#$%^&*AU2025205489A120250814.pdf##### Abstract Liquid suspensions oftasimelteon and methods for their use. Abstract Liquid suspensions oftasimelteon and methods for their use.

Drugs covered by this patent

Patent Metadata

Patent number: AU2025205489A1
Jurisdiction: AU
Classification: —
Expires: 2025-08-14
Drug substance claim: No
Drug product claim: No
Assignee: Vanda Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.